ClinicalTrials.Veeva

Menu

Effect of Non-alcoholic Fatty Liver Disease on Kidney Functions

A

Assiut University

Status

Unknown

Conditions

Liver Diseases

Treatments

Diagnostic Test: glomerular filtration rate

Study type

Observational

Funder types

Other

Identifiers

Details and patient eligibility

About

Non-alcoholic fatty liver disease is the most common cause of chronic liver disease worldwide. It is defined as the accumulation of fat (>5%) in the liver cells in the absence of excessive alcohol intake or other causes of liver disease including viral, drug-induced, or autoimmune. Non-alcoholic fatty liver disease is a hepatic manifestation of metabolic syndrome.

Enrollment

120 estimated patients

Sex

All

Ages

18 to 70 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • All non alcoholic fatty liver disease patients evidenced by abdominal ultrasound.
  • Urine analysis whether normal or renal sedimentation.

Exclusion criteria

  1. Alcoholic fatty liver patients.
  2. patients known to have diabetes mellitus.
  3. patients with other causes of liver disease as viral hepatitis, drug induced,or autoimmune.
  4. patients known to have kidney disease.
  5. Hypertension.
  6. Hyperuricemia.
  7. Impaired urea and creatinine patients.

Trial design

120 participants in 2 patient groups

study group
Description:
non alcoholic fatty liver disease patients
Treatment:
Diagnostic Test: glomerular filtration rate
Control group
Description:
fatty liver patients
Treatment:
Diagnostic Test: glomerular filtration rate

Trial contacts and locations

1

Loading...

Central trial contact

Mahmoud Ali, MBBCh

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems